Tirzepatide and the NHS: are we creating a two-tier obesity treatment system?

a Note this table does not include the full NICE tirzepatide funding variation criteria or SFE/OMC-UK phase 1 criteria and phase 2 to 4 criteria due to space constraints.Please see the NICE guideline and SFE/OMC-UK position statement for further details.b All prescriptions require wrap-around care, including a reduced-calorie diet and increased physical activity within a comprehensive obesity-management plan.Contraception is required while taking these medications ahead of planned assisted conception.12 c Apply ethnicity-adjusted BMI thresholds (typically -2.5 kg/m² for minority ethnic groups).